- Home
- Struttura
- Programmi di finanziamento
- EDCTP - European & Developing Countries Clinical Trials Partnership
EDCTP - European & Developing Countries Clinical Trials Partnership
EDCTP was formed by a European Parliament and European Council decision in order to pool resources, funding and activities to achieve a greater impact against the three poverty-related diseases. EDCTP aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria, with a focus on phase II and III clinical trials in sub-Saharan Africa. EDCTP supports multicentre projects that combine clinical trials, capacity building and networking. The aim of integrating these three activities is to ensure that the developed capacity is optimally utilised to successfully conduct the clinical trials in a sustainable way. The basis of EDCTP is partnership. The partnership helps EU Member States to integrate and coordinate their own national research and development programmes and form partnerships with their African counterparts. All EDCTP-funded projects are undertaken in partnership with sub-Saharan countries. EDCTP currently unites 14 participating European Union (EU) Member States: Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom + Norway and Switzerland with sub-Saharan African countries. EDCTP will launch each year one or more calls to finance specific projects.
https://www.uniud.it/it/struttura/programmi-aric/european-developing-countries-clinical-trials-partnership-edctp
https://www.uniud.it/@@site-logo/logo-uniud.svg

EDCTP - European & Developing Countries Clinical Trials Partnership
EDCTP was formed by a European Parliament and European Council decision in order to pool resources, funding and activities to achieve a greater impact against the three poverty-related diseases. EDCTP aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria, with a focus on phase II and III clinical trials in sub-Saharan Africa. EDCTP supports multicentre projects that combine clinical trials, capacity building and networking. The aim of integrating these three activities is to ensure that the developed capacity is optimally utilised to successfully conduct the clinical trials in a sustainable way. The basis of EDCTP is partnership. The partnership helps EU Member States to integrate and coordinate their own national research and development programmes and form partnerships with their African counterparts. All EDCTP-funded projects are undertaken in partnership with sub-Saharan countries. EDCTP currently unites 14 participating European Union (EU) Member States: Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom + Norway and Switzerland with sub-Saharan African countries. EDCTP will launch each year one or more calls to finance specific projects.